Regeneron is interested in obesity treatments that combat muscle loss — potentia...
The investment arm of Novo Nordisk’s parent foundation is buying Catalent, a con...
An investment group tied to Novo Nordisk is buying drug manufacturer Catalent fo...
The new obesity drugs are effective but expensive and usually need to be taken f...
Cancer cases around the world are expected to surge 77% by 2050. A new WHO repor...
Why the debate over proposed nursing home staff minimums is particularly unprodu...
A new Medicare Advantage plan rule went largely overlooked, but recent financial...
A new bipartisan bill, if passed, would direct the FDA to force digital device m...
"The more we involve people who are living with the challenges, the faster progr...
Devoted Health, a prominent health insurance and provider startup, has not turne...
Documents released this week shed new light on an aggressive strategy from Juul ...
Petrina Kamya, PhD, Head of AI Platforms and President of Insilico Medicine Cana...
Gastrointestinal cancers (GCs) are among the most common forms of cancer and acc...
COLUMBIA, Mo. — Nearly one-third of Missouri’s economy is tied to agriculture. T...
“[…] fruitful efforts to bring more drugs from bench to bedside could only be po...
Scientists from the University of Rochester’s Laboratory for Laser Energetics (L...
